The Capital Group increased its holdings in Hengrui Pharmaceuticals (01276.HK) by approximately 578,900 shares at a price of approximately HK$48.07 per share.

Zhitong Finance APP has learned that the latest data from the Hong Kong Stock Exchange shows that on September 21, Capital Group increased its holdings of Hengrui Pharmaceuticals (01276.HK) by 578,855 shares at HK$48.0679 per share, for a total amount of approximately HK$27.8243 million. After the increase, its latest shareholding was approximately 28.834 million shares, with its latest shareholding ratio at 11.17%.